TENX — Tenax Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $16.19m
- $7.09m
- 29
- 20
- 21
- 12
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 5.4 | 6.71 | 5.58 | 2.12 | 9.79 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 6.18 | 6.8 | 5.69 | 3.21 | 11.7 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.176 | 0.065 | 0.295 | 0.187 | 0 |
Other Long Term Assets | |||||
Total Assets | 6.37 | 6.87 | 5.99 | 3.4 | 11.7 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Current Liabilities | 2.53 | 2.12 | 1.56 | 1.85 | 3.59 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.59 | 2.24 | 1.75 | 1.91 | 3.59 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 3.77 | 4.63 | 4.24 | 1.49 | 8.1 |
Total Liabilities & Shareholders' Equity | 6.37 | 6.87 | 5.99 | 3.4 | 11.7 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |